CDMO stock forecast
Our latest prediction for Avid Bioservices, Inc.'s stock price was made on the Sept. 10, 2019 when the stock price was at 5.07$.
In the short term (2weeks), CDMO's stock price should outperform the market by 4.88%. During that period the price should oscillate between -8.59% and +16.18%.
In the medium term (3months), CDMO's stock price should outperform the market by 5.46%. During that period the price should oscillate between -18.67% and +41.37%.Get email alerts
Create a solid portfolio with CDMO
About Avid Bioservices, Inc.
Avid Bioservices, Inc. engages in the commercial manufacturing which focuses on biopharmaceutical products derived from mammalian cell culture for culture for biotechnology and pharmaceutical companies. The firm specializes in clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory submissions, and support. The company was founded on June 3, 1981 and is headquartered in Tustin, CA.
At the moment the company generates 56M USD in revenues.
On its last earning announcement, the company reported a loss of -0.18$ per share.
The book value per share is 1.01$
Three months stock forecastSept. 10, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|